Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02MST
|
||||
Former ID |
DIB018635
|
||||
Drug Name |
5-(nonyloxy)-tryptamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H30N2O
|
||||
InChI |
InChI=1S/C19H30N2O/c1-2-3-4-5-6-7-8-13-22-17-9-10-19-18(14-17)16(11-12-20)15-21-19/h9-10,14-15,21H,2-8,11-13,20H2,1H3
|
||||
InChIKey |
YHSMSRREJYOGQJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
5244805, 8151290, 11113772, 14776228, 26751955, 29220996, 47217007, 47440494, 57321029, 74606294, 85209666, 85789470, 103142531, 103309415, 103947142, 104298749, 117534335, 129797481, 134340944, 135088539, 135610592, 135649844, 137054299, 162219823, 162797793, 179236163, 184590372, 228455448, 245050255
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | Agonist | [2] | |
KEGG Pathway | cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathway | |||||
Reactome | Serotonin receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Serotonin HTR1 Group and FOS Pathway | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 106). | ||||
REF 2 | Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor. Eur J Pharmacol. 1999 Sep 10;380(2-3):171-81. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.